Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Akip1em1/Cya
Common Name:
Akip1-KO
Product ID:
S-KO-11016
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Akip1-KO
Strain ID
KOCMP-57373-Akip1-B6N-VA
Gene Name
Akip1
Product ID
S-KO-11016
Gene Alias
BCA3; C11orf17; D7H11orf17; D930014E17Rik; ICRFP703B1614Q5.6; ORF27
Background
C57BL/6NCya
NCBI ID
57373
Modification
Conventional knockout
Chromosome
7
Phenotype
MGI:3041226
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Akip1em1/Cya mice (Catalog S-KO-11016) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000033335
NCBI RefSeq
NM_020616
Target Region
Exon 4
Size of Effective Region
~0.3 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Akip1, or A Kinase Interacting Protein 1, is a signaling adaptor involved in multiple cellular processes. It has been associated with various pathways such as NF-κB, AKT, Wnt/β-catenin, and is crucial for physiological cardiac remodelling and also plays a significant role in cancer-related processes [1,5,6]. In cancer, it is linked to tumorigenesis, metastasis, angiogenesis, and chemoradiotherapy resistance [1,2,3,4,5,7,8]. Genetic models are valuable in studying Akip1's function as they can help elucidate its role in normal and disease-related biological processes.

In glioblastoma, down-regulating Akip1 impaired cell proliferation, colony formation, and tumorigenicity. Akip1 stabilizes EGFR by cooperating with YY1-mediated HSP90AA1 transcriptional activation [1]. In endometrial carcinoma, elevated Akip1 expression was associated with tumor invasion, shorter survival, and decreased chemosensitivity, and silencing Akip1 enhanced cisplatin sensitivity in Ishikawa cells [2]. In glioblastoma again, Akip1 promoted cell viability, mobility, and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways [3]. In tongue squamous cell carcinoma, overexpression of Akip1 increased cell proliferation, migration, and invasion, and mRNA sequencing revealed its involvement in mTOR, PI3K-Akt, MAPK, Hippo, and Wnt signaling pathways [4]. In hepatocellular carcinoma, Akip1 promoted early recurrence by activating the Wnt/β-catenin/CBP signaling pathway [5].

In conclusion, Akip1 has diverse functions in both normal physiological processes like cardiac remodelling and in disease, especially cancer. Through gene-knockout or knockdown models in various cancer types, its role in promoting tumor progression, metastasis, and influencing chemosensitivity has been revealed. These findings highlight the importance of Akip1 as a potential therapeutic target in cancer treatment.

References:

1. Wan, Sicheng, Liu, Chaolong, Li, Chongyang, Zhang, Li, Cui, Hongjuan. 2023. AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression. In Oncogene, 42, 2905-2918. doi:10.1038/s41388-023-02796-2. https://pubmed.ncbi.nlm.nih.gov/37596322/

2. Li, Aili, Li, Aijing, Gao, Xiangpeng, Xiao, Yalin, Zhao, Fei. 2022. Elevated AKIP1 expression is associated with tumor invasion, shorter survival time and decreased chemosensitivity in endometrial carcinoma. In Oncology letters, 24, 268. doi:10.3892/ol.2022.13388. https://pubmed.ncbi.nlm.nih.gov/35782897/

3. Han, Dayong, Zhang, Na, Zhao, Shu, Liu, Zhanwen, Teng, Lei. 2021. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways. In American journal of cancer research, 11, 1185-1205. doi:. https://pubmed.ncbi.nlm.nih.gov/33948353/

4. Wang, Ning, Bai, Dan, Kristiansen, Einar, Deng, Ruoyu, Zhang, Shijun. 2021. AKIP1 promotes tumor progression by cancer-related pathways and predicts prognosis in tongue squamous cell carcinoma. In American journal of translational research, 13, 12338-12351. doi:. https://pubmed.ncbi.nlm.nih.gov/34956456/

5. Cui, Yanmei, Wu, Xianqiu, Lin, Chuyong, Guan, Jian, Song, Libing. 2019. AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway. In Oncogene, 38, 5516-5529. doi:10.1038/s41388-019-0807-5. https://pubmed.ncbi.nlm.nih.gov/30936461/

6. Nijholt, Kirsten T, Sánchez-Aguilera, Pablo I, Booij, Harmen G, Silljé, Herman H W, Westenbrink, B Daan. 2023. A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling. In Scientific reports, 13, 4046. doi:10.1038/s41598-023-30514-1. https://pubmed.ncbi.nlm.nih.gov/36899057/

7. Zhang, Wenying, Wu, Qiongwei, Wang, Chao, Liu, Ping, Ma, Chengbin. 2018. AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells. In Molecular and cellular biochemistry, 448, 311-320. doi:10.1007/s11010-018-3335-7. https://pubmed.ncbi.nlm.nih.gov/29520695/

8. Guo, Xiaobin, Zhao, Limin, Cheng, Dongjun, Kuang, Hongyan, Feng, Keqing. 2017. AKIP1 promoted epithelial-mesenchymal transition of non-small-cell lung cancer via transactivating ZEB1. In American journal of cancer research, 7, 2234-2244. doi:. https://pubmed.ncbi.nlm.nih.gov/29218247/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest